Interactive Bayer Case Study on Oncology

Wednesday, Nov 1, 2017

Just 8 spaces left!


Bayer LifeHub Boston
Kendall Square
5:00PM - 9:00PM
$30 GABC Members
$45 Non-Members

Calendar Link


If you are a member, you should sign in to take advantage of member pricing, and your checkout details will be filled automatically.

Number of tickets:

Total: $0

Pay by check

Become an employee at a pharmaceutical company for one day and learn how industrial drug development works!  A unique 4-hour role-playing workshop for anyone who has wondered what it’s like to work for a pharmaceutical company.

GABC is thrilled to partner with Bayer in this interactive, learning‐through‐experiencing approach which provides insights into the pharma business model in a time lapse, making the drug development process transparent and easier to understand. Within global project teams, you will get to discuss and decide which projects will be developed further and which ones won’t. Questions relating to drug benefits and risks, patents, or economic viability need to be considered. At the same time, competitors and health technology assessment bodies are also in the game.

Our Scenario:

Our theme will be Closing in on Cancer – New Therapies for Cancer Patients.  We’ll introduce you to a fictitious company, with background details related to its research areas, marketed products, location, and market shares.

For the case study, we simplify the situation, and assume that our fictitious company is currently pursuing four drug candidates which are in different research and development stages. We’ll introduce you to the candidates –- what they do, where they would be sold, potential applications, innovation strategies, and development processes. Ultimately, we’ll introduce you to the critical challenges that these product candidates face. Participants in the case study will be “assigned” to roles within specific departments, such as Drug Discovery, Clinical Development, Marketing or Regulatory Affairs, thus gaining a unique insight into the workings of a major pharma company and the challenges they must overcome.

Event location:
Bayer  / LifeHub Boston
610 Main Street (entrance from Portland Street)
Cambridge, MA

Date: Wednesday, Nov. 1, 2017

Time: 5:00PM – 9:00PM

Cost: $30 GABC Members / $45 Non-members
Includes Networking Reception and refreshments following workshop

RSVP: Because of the hands-on nature of this event, it will be limited to 28 active participants, with preference given to GABC Members.  If you think you want to join this event, please don’t delay. No spots will be guaranteed until your online registration and payment is complete.

Bayer LifeHub logo
About Bayer:

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At Pharmaceuticals, Bayer’s largest segment in terms of sales, the focus is on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. For more information, go to

About LifeHub Boston, the first of a global network of innovation spaces by Bayer where science meets society:
At LifeHub Boston (located in Kendall Square, Cambridge), we believe that creating breakthrough solutions to global health challenges requires creative thinking and radical collaboration across industries and mindsets. That’s why we convene people with diverse and passionate perspectives—from life scientists to policy makers, entrepreneurs to artists, software engineers to farmers—to create impact at the intersections of health, agriculture, and technology. Through events that dive deep into complex and controversial issues, cross-disciplinary research projects, and residencies for entrepreneurs and startups, we will design solutions both with and for the public. Together, we can create better lives for humans, animals, and plants.

Photo by permission Bayer / LifeHub Boston